Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Management of Lp(a).

Brown WV, Ballantyne CM, Jones PH, Marcovina S.

J Clin Lipidol. 2010 Jul-Aug;4(4):240-7. doi: 10.1016/j.jacl.2010.07.002. Epub 2010 Jul 14. No abstract available. Erratum in: J Clin Lipidol. 2010 Nov-Dec;4(6):548.

PMID:
21122656
2.

Cringle conundrums, clotting, cholesterol, and coronaries.

Luft FC.

J Mol Med (Berl). 1996 Nov;74(11):637-8. No abstract available.

PMID:
8956149
3.

The assembly of lipoprotein Lp(a).

Frank S, Durovic S, Kostner GM.

Eur J Clin Invest. 1996 Feb;26(2):109-14. Review. No abstract available.

PMID:
8904519
4.

[Lipoprotein (a) and stroke].

Ferraro M, Spagnuolo V, Sprovieri M, Mauro GF.

Minerva Med. 2008 Aug;99(4):399-409. Review. Italian.

PMID:
18663347
5.

A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation.

Hill BC, Becker L, Anand V, Kusmierczyk A, Marcovina SM, Rahman MN, Gabel BR, Jia Z, Boffa MB, Koschinsky ML.

Arch Biochem Biophys. 2003 Apr 15;412(2):186-95.

PMID:
12667482
6.
7.

Lipoprotein(a): Looking ahead.

Scanu AM.

Nutr Metab Cardiovasc Dis. 2005 Oct;15(5):331-3. Epub 2005 Sep 30. No abstract available.

PMID:
16216717
8.

Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.

Xue S, Green MA, LoGrasso PV, Boettcher BR, Madison EL, Curtiss LK, Miles LA.

Thromb Haemost. 1999 Mar;81(3):428-35.

PMID:
10102473
9.

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.

Schneider M, Witztum JL, Young SG, Ludwig EH, Miller ER, Tsimikas S, Curtiss LK, Marcovina SM, Taylor JM, Lawn RM, Innerarity TL, Pitas RE.

J Lipid Res. 2005 Apr;46(4):769-78. Epub 2005 Jan 16.

10.

Structure and possible biological roles of Lp(a).

Karmansky I, Gruener N.

Clin Biochem. 1994 Jun;27(3):151-62. Review.

PMID:
7923754
11.

Analysis of structure--function relationships in human apolipoprotein(a).

van der Hoek YY, Kastelein JJ, Koschinsky ML.

Can J Physiol Pharmacol. 1994 Mar;72(3):304-10.

PMID:
8069777
12.

The role of apo-(a) kringle-IVs in the assembly of lipoprotein-(a).

Frank S, Kostner GM.

Protein Eng. 1997 Mar;10(3):291-8.

PMID:
9153080
13.

Lipoprotein(a): a new independent risk factor for atherosclerosis.

Fulcher G.

Aust N Z J Med. 1992 Aug;22(4):326-8. No abstract available.

PMID:
1445018
14.

Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins.

Gaubatz JW, Hoogeveen RC, Hoffman AS, Ghazzaly KG, Pownall HJ, Guevara J Jr, Koschinsky ML, Morrisett JD.

J Lipid Res. 2001 Dec;42(12):2058-68.

15.

Lp(a) lipoprotein--coping with heterogeneity.

Scanu AM.

N Engl J Med. 2003 Nov 27;349(22):2089-90. No abstract available.

PMID:
14645635
16.
17.

Lipoprotein(a) in children and adolescence.

Wang XL, Wang J.

Pediatr Endocrinol Rev. 2003 Dec;1(2):109-19. Review.

PMID:
16437016
18.

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.

Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ Jr, Simari RD.

Blood. 2001 Nov 15;98(10):2980-7.

19.

Apoprotein-phospholipid interactions in Lp(a).

Hermetter A, Sommer A, Gorges R, Prenner E, Kostner GM, Paltauf F.

Chem Phys Lipids. 1994 Jan;67-68:115-9.

PMID:
8187205
20.

Comparison of the effects of O2*-/HO* free radical- and copper ions-oxidized LDL or lipoprotein(a) on the endothelial cell releases of tissue plasminogen activator and plasminogen activator inhibitor-1.

Beaudeux JL, Therond P, Bonnefont-Rousselot D, Gardes-Albert M, Legrand A, Delattre J, Peynet J.

Life Sci. 2001 Oct 5;69(20):2371-82.

PMID:
11681624

Supplemental Content

Support Center